Skip to content

Association of CircRNA with Intracranial Aneurysm and Predictive Value of HDL in the Development, Rupture and Prognosis of Intracranial Aneurysms

Association of CircRNA with Intracranial Aneurysm and Predictive Value of HDL in the Development, Rupture and Prognosis of Intracranial Aneurysms

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016485
Enrollment
Unknown
Registered
2018-06-04
Start date
2018-06-02
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial aneurysm and aneurysmal subarachnoid hemorrhage

Interventions

Case series:Nil

Sponsors

First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. January 2010-present Neurosurgery at the First and Second Hospitals of Fujian Medical University admitted patients with spontaneous subarachnoid hemorrhage; 2. persons older than 18 years of age; 3. All patients should be diagnosed as ruptured intracranial aneurysms by brain CT scan, CT angiography (CTA) or whole brain angiography (DSA); 4. Interventions were performed using craniotomy or interventional endovascular embolization; 5. No major systemic disease associated with the systemic system may affect various indicators and prognosis; 6. can meet the interview or follow-up, provide relevant information and obtain clinical data.

Exclusion criteria

Exclusion criteria: 1. The first head CT scan or negative lumbar puncture; 2. Intracranial tumors, craniocerebral trauma, intracranial arteriovenous malformations and other brain diseases; 3. Patients with coagulopathy and history of brain surgery; 4. Incomplete clinical data cannot complete this researcher; 5. Incorporate other serious cardiovascular and cerebrovascular diseases; 6. Other non-aneurysmal subarachnoid hemorrhage (such as venous malformation, hypertensive intracerebral hemorrhage, moyamoya disease, etc.). One of the above is deleted; 7. Conservative treatment or abandon treatment; delete if one of the above is met.

Design outcomes

Primary

MeasureTime frame
mRS score;DIND;

Countries

China

Contacts

Public ContactYao Peisen

First Affiliated Hospital of Fujian Medical University

peisen.yao@163.com+86 18650084102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026